Ali Khavanin

Ali Khavanin

Auto-generated profile, based on publicly available information

Ali Khavanin

Department of Emergency Medicine, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Emergency Medicine International
Verified
Journal Article
Open access
PDF file
KMKambiz Masoumi
Kambiz Masoumi
AFArash Forouzan
Arash Forouzan
ADAli Asgari Darian
Ali Asgari Darian
MFMaryam Feli
Maryam Feli
HBHassan Barzegari
Hassan Barzegari
AKAli Khavanin
Ali Khavanin
The aim of this study was to compare the clinical efficacy of intravenous acetaminophen with intravenous morphine in acute renal colic pain management. In this double-blind controlled trial, patients aged 18–55 years, diagnosed with acute renal colic, who met the inclusion and exclusion criteria, were randomized into two groups. First, using the visual analogue scale (VAS), intensity of pain was assessed in both groups. Then, one gram of intravenous acetaminophen or 0.1 mg/kg morphine was infused in 100 mL normal saline to either acetaminophen or morphine group. Intensity of pain was reassessed in 15, 30, 45, and 60 minutes according to VAS criteria. Finally, data from 108 patients were analyzed, 54 patients in each group. No significant difference was observed between the two groups in regard to sex (P=0.13), mean age (P=0.54), and baseline visual analogue score (P=0.21). A repeated measure analysis of variance revealed that the difference between the two treatments was significant (P=0.0001). The VAS reduction at primary endpoint (30 min after drug administration) was significantly higher in the acetaminophen group than in the morphine group (P=0.0001). This study demonstrated that intravenous acetaminophen could be more effective than intravenous morphine in acute renal colic patients’ pain relief.

1 March 2015
Verified
Journal Article
Closed access
MTMojtaba Tabrizi
Mojtaba Tabrizi
MKMitra Khalili
Mitra Khalili
MVMohammad Vasei
Mohammad Vasei
NNNazila Nouraee
Nazila Nouraee
NSNader Mansour Samaei
Nader Mansour Samaei
SMSeyed Javad Mowla
Seyed Javad Mowla

28 May 2017
Verified
Journal Article
Open access
AFArash Forouzan
Arash Forouzan
HBHassan Barzegari
Hassan Barzegari
HMHassan Motamed
Hassan Motamed
AKAli Khavanin
Ali Khavanin
HSHamideh Shiri
Hamideh Shiri
Considering the existing contradictions regarding effectiveness of intravenous (IV) lidocaine, especially in emergency department (ED), the present study was designed to compare the analgesic effect of IV lidocaine and morphine sulfate in pain management for extremity bone fractures. In this triple blind clinical trial, 15 to 65 year-old patients with extremity fractures and in need of pain management were randomly allocated to either IV lidocaine or morphine sulfate group and were compared regarding severity of pain 5, 10, 15, 20, 25, and 30 minutes after infusion via intention to treat analysis. The absolute risk reduction, number needed to treat and relative risk of IV lidocaine after 30 minutes were 0.40 (95%CI: 0.25 – 0.64), 7 (95%CI: 3.7 – 23.1), and 20.71 (95%CI: 10.91 – 30.51), respectively. 280 patients with the mean age of 32.50 ± 12.77 years were randomly divided into 2 equal groups of 140 (73.9% male). The 2 groups had similar baseline characteristics. 15 minutes after injection success rate was 49.28% in lidocaine and 33.57% in morphine sulfate group (p = 0.011), and after 30 minutes it reached 85.71% and 65.00%, respectively (p < 0.001). Based on the results of the present study, IV lidocaine could be considered as a reasonable alternative choice for pain management in ED.

26 March 2015 in Case Reports in Pediatrics
Verified
Journal Article
Open access
PDF file
KMKambiz Masoumi
Kambiz Masoumi
AFArash Forouzan
Arash Forouzan
HSHossein Saidi
Hossein Saidi
HJHazhir Javaherizadeh
Hazhir Javaherizadeh
AKAli Khavanin
Ali Khavanin
MBMohammad Bahadoram
Mohammad Bahadoram
Kawasaki disease is generally known as a systemic vasculitis that often concerns doctors due to its serious cardiac complications; however, other visceral organs may get involved as well. Surgical manifestations of the intestinal tract in Kawasaki disease are rare. In this report, we describe the case of a 2.5-year-old boy with typical Kawasaki disease who presented with GI bleeding and surgical abdomen. The diagnosis of duodenal perforation was confirmed.

25 December 2021 in Immunopathologia Persa
Verified
Journal Article
Open access
KMKambiz Masoumi
Kambiz Masoumi
AKAli Khavanin
Ali Khavanin
MMMeisam Moezzi
Meisam Moezzi
HHHabib Heybar
Habib Heybar
NRNastaran Ranjbari
Nastaran Ranjbari
MMMehdi Mokhtari
Mehdi Mokhtari
Introduction: It is necessary to identify tests that have high diagnostic power in the early hours of acute myocardial infarction. Objectives: In this study, we investigated the major histocompatibility complex class I chain-related molecule A (MICA) in the serum of patients with myocardial infarction (MI). Patients and Methods: In this study, 65 patients with MI were studied. Creatine phosphokinase-MB (CPK-MB), troponin I, and MICA biomarkers were measured at different times after hospitalization (0, 3, 6, 9, 12 and, 24 hours). These biomarkers were evaluated at different times after chest pain (0 to 3, 3 to 6, and more than 6 hours). Results: Serum MICA biomarker increased significantly from admission to the hospital until 3 hours. Later on, it decreased until 24 hours. However, CPK-MB biomarkers as well as troponin I, change from admission up to 24 hours. Regarding diagnostic power, it was found that the diagnostic power of MICA is high in the early hours which indicates the high diagnostic power of the test. Conclusion: The diagnostic value of MICA is significant in the early hours after MI. Therefore, due to the high accuracy of MICA in diagnosing MI, it should be used as a diagnostic test along with other tests to confirm MI in the early hours.

3 February 2026 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
MSMohadeseh Sheykhi-Sabzehpoush
Mohadeseh Sheykhi-Sabzehpoush
HAHamed Abedzeydi
Hamed Abedzeydi
MSMaryam Khombi Shooshtari
Maryam Khombi Shooshtari
MCMaryam Cheraghzadeh
Maryam Cheraghzadeh
FMFarideh Moramezi
Farideh Moramezi
MFmaryam farzaneh
maryam farzaneh